Similar biologics to mepolizumab (what patients usually mean)
Mepolizumab (Nucala) is an anti–IL-5 monoclonal antibody used for certain eosinophilic diseases, especially severe eosinophilic asthma. “Similar to mepolizumab” usually refers to other drugs that lower eosinophils by blocking the same pathway (IL-5/IL-5R) or that are used for similar patient populations.
Which drugs work in the same IL-5 pathway?
The closest functional “similar” options are other therapies targeting IL-5 signaling:
- Benralizumab (anti–IL-5R). It targets the IL-5 receptor on immune cells, leading to eosinophil reduction. It’s used for severe eosinophilic asthma in similar clinical settings.
- Reslizumab (anti–IL-5). It directly targets IL-5 and is also used for severe eosinophilic asthma.
Because these are designed for the same disease mechanism (reducing eosinophils), they are the most direct comparisons to mepolizumab.
How are these options different from each other?
Even when they’re used for the same condition, differences can matter to patients and clinicians:
- Target: mepolizumab and reslizumab block IL-5 ligand, while benralizumab blocks the IL-5 receptor.
- Administration and dosing patterns can differ by product and label (route, injection vs infusion, and dosing frequency).
- Eligibility criteria: each has specific requirements tied to eosinophil counts and asthma history.
If you mean “similar for severe asthma,” what’s the real decision point?
Clinicians typically look at:
- Your baseline eosinophil level and history of exacerbations.
- Prior treatments tried (including inhaled corticosteroids and other controllers).
- Whether a specific IL-5-targeting option fits the dosing/administration pattern you can maintain.
Those factors often drive whether someone stays on mepolizumab or switches to benralizumab or reslizumab.
Are there other “similar” drugs that treat eosinophilic disease but not IL-5?
Some eosinophilic conditions use different biologic targets (for example, therapies aimed at IL-4/IL-13 or IgE). If your question is really about eosinophilic asthma but not necessarily IL-5 biology, tell me your diagnosis and what you’re trying to compare, and I can narrow the match.
Quick check so I can give the most accurate “similar” list
Are you asking for:
1) Other IL-5/IL-5R biologics for severe eosinophilic asthma (mepolizumab alternatives), or
2) Similar drugs for a different eosinophilic condition (like nasal polyps), or
3) A medication that’s “similar” in effect but by a different mechanism?
Reply with the condition you’re treating and (if you know it) whether you mean switching from Nucala, and I’ll tailor the comparison.